FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TASELISIB
异名/同义词1H-PYRAZOLE-1-ACETAMIDE, 4-(5,6-DIHYDRO-2-(3-METHYL-1-(1-METHYLETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)-.ALPHA.,.ALPHA.-DIMETHYL-
2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO(F)IMIDAZO(1,2-D)(1,4)OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE
GDC-0032
RG-7604
TASELISIB
TASELISIB [INN]
TASELISIB [USAN]
TASELISIB [WHO-DD]
CAS登记号1282512-48-4
物质唯一标识(Unique Ingredient Identifier)L08J2O299M
分子式9815
国际化合物标识(International Chemical Identifier,InChI)BC-99
SMILESC24H28N8O2
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型BEUQXVWXFDOSAQ-UHFFFAOYSA-N / C(C(C)(C)n1ncc(c1)-c2cc3c(-c4n(CCO3)cc(n4)-c5nc(nn5C(C)C)C)cc2)(=O)N
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System